ClinicalTrials.Veeva

Menu

Effectiveness and Safety of Probiotic in Regulating Chronic Constipation

W

Wecare Probiotics

Status

Completed

Conditions

Chronic Constipation

Treatments

Dietary Supplement: Probiotic
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT05980988
WK2023003

Details and patient eligibility

About

To evaluate the effectiveness and safety of the use of probiotics as food supplements in regulating the intestinal habit of subjects with chronic constipation, in comparison with placebo.

Enrollment

46 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients with chronic constipation (duration more than 3 months with less than three bowel movements per week and/or Bristol Scale 1 and 2).

Exclusion criteria

  1. Diabetic patients.
  2. Pregnant patients.
  3. Breastfeeding patients.
  4. Patients requiring antibiotic treatment.
  5. Patients requiring treatment with tricyclic antidepressants, antiepileptics, antihistamines, antiparkinsonians, antipsychotics, antispasmodics, verapamil, monoamine oxidase inhibitors, opiates, sympathomimetics, antacids (with aluminum and calcium), antidiarrheals and nonsteroidal anti-inflammatory drugs.
  6. Patients who change the type of diet during the study.
  7. Patients with allergy or intolerance to any of the ingredients in the formulation of the product under study.
  8. Subjects with a history of pharmacological, alcoholic, or other substance abuse, or other factors that limit their ability to cooperate during the study.
  9. Excessive alcohol consumption (>3 glasses of wine or beer/day).
  10. Subjects whose condition does not make them eligible for the study, according to the researcher.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

46 participants in 2 patient groups, including a placebo group

Probiotic group
Experimental group
Description:
2B CFU/capsule/day BLa80, before meals; Storage: Store in a cool, dry place without sun exposure.
Treatment:
Dietary Supplement: Probiotic
placebo
Placebo Comparator group
Description:
Maltodextrin, one capsule/day, before meals; Storage: Store in a cool, dry place without exposure to the sun.
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems